Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58724 ) - R3 - Effective March 12, 2024

Date Posted: March 21, 2024

This coverage article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Effective Date: March 12, 2024

Summary of Article Changes:

Under CPT/HCPCS Codes Group 1: Codes added 0005U. Under CPT/HCPCS Codes Group 2: Codes added 0005U. This revision is due to new covered assay that has successfully completed a TA and is effective 12/27/2023.

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

Last Updated Apr 08 , 2024